BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31352623)

  • 1. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic pseudomass by MR cholangio-pancreatography: utility of the duct-interrupted, corona, and attraction signs.
    Beker K; Lee KS; Tsai LL; Hegazi T; Garces-Descovich A; Brook A; Mortele KJ
    Abdom Radiol (NY); 2019 Dec; 44(12):4048-4056. PubMed ID: 31352623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.
    Kawakami S; Fukasawa M; Shimizu T; Ichikawa S; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Hayakawa H; Nakayama Y; Yamaguchi T; Inoue T; Maekawa S; Kawaida H; Motosugi U; Onishi H; Enomoto N
    Medicine (Baltimore); 2019 Nov; 98(47):e18039. PubMed ID: 31764824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatitis and PDAC: association and differentiation.
    Elsherif SB; Virarkar M; Javadi S; Ibarra-Rovira JJ; Tamm EP; Bhosale PR
    Abdom Radiol (NY); 2020 May; 45(5):1324-1337. PubMed ID: 31705251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
    Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
    Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas.
    Ichikawa T; Sou H; Araki T; Arbab AS; Yoshikawa T; Ishigame K; Haradome H; Hachiya J
    Radiology; 2001 Oct; 221(1):107-16. PubMed ID: 11568327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
    Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
    Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP.
    Carbognin G; Girardi V; Biasiutti C; Camera L; Manfredi R; Frulloni L; Hermans JJ; Mucelli RP
    Radiol Med; 2009 Dec; 114(8):1214-31. PubMed ID: 19789959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance cholangiopancreatography of pancreaticobiliary duct dilation due to pancreatic carcinoma and chronic pancreatitis.
    Meng Z; Xu YK; Zhang YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):113-5. PubMed ID: 18524063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
    Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
    Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
    Aslan S; Nural MS; Camlidag I; Danaci M
    Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
    Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
    Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
    Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
    Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma.
    Kang JD; Clarke SE; Costa AF
    Eur Radiol; 2021 Apr; 31(4):2422-2432. PubMed ID: 32997176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mimickers of pancreatic adenocarcinoma.
    Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
    Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
    Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
    Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
    Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
    AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.